FP7 logo euThe SATURN project has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement n°241796

Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria

Partners: Università Cattolica Sacro Cuore – (UCSC)

The organisation

UCSCThe “Università Cattolica del Sacro Cuore”, School of Medicine is a world-class training ground for future leaders in medical research and practice, including every modern medical discipline. Medical students receive a portion of their clinical training at the Agostino Gemelli Hospital, a 1850-beds hospital that achieved an increasing relevance at both national and international level in the last 30 years. The Institute of Infectious Diseases at the UCSC has a 40-bed unit and a large outpatient clinic for more than 10’000 visits a year. The group of researchers has a vast experience in the epidemiology and clinical aspects of nosocomial and community-acquired infections caused by multi-drug resistant bacteria. Our research unit was partner in two projects financed by the European Commission within a FP5 IST project (TREAT) and a FP6 project (AMICA). The Institute of Infectious Diseases and Microbiology will coordinate WP4 (Nosocomial acquisition study) and will participate to WP5 (Nosocomial follow-up study) as clinical center.

Key staff involved in the project

Evelina TacconelliEvelina Tacconelli, (MD, MS, PhD) is Assistant Professor of Infectious Diseases at the UCSC, Lecturer on Medicine at the Beth Israel Deaconess Medical Center, and Harvard Medical School, Boston, USA, and Assistant Professor of Public Health at the Trnava University, Slovakia. She is leading the workpackage 4 (risk assessment for MRSA) within the European ISC MRSA working group. Her scientific activity mainly developed in the fields of bacterial infections mostly concerning aspects related to nosocomial infections and antimicrobial resistance. She published > 80 papers in peer-reviewed scientific journals. She has experience in working in projects funded by the EU Commission and is currently leading two international and one national networks on the theme of AMR. She is involved in this project as WP4 leader.

Roberto CaudaRoberto Cauda, (MD, PhD). Professor and chairman of Infectious Diseases and Director of School Specialisations on Infectious Diseases and Tropical Medicine at the UCSC. Author of more than 200 papers. Areas of scientific interest: antibiotic resistance and nosocomial infections, clinical and epidemiological aspects of HIV disease. He has experience in working in projects funded by the EU Commission.

Giovanni FaddaGiovanni Fadda, (MD) is a Professor of Microbiology, Head of the Department of the Microbiology at the UCSC. He is a consultant for the WHO. His scientific activity runs through virology, bacteriology, diagnostic microbiology and molecular biology, with more than 200 publications in international journals.

Giulia De AngelisGiulia De Angelis, (MD) is a PhD student expert in the epidemiology and clinical aspects of nosocomial infections due to multidrug resistant pathogens.

Gabriele Sganga, (MD) Associate Professor of Surgery, Department of Surgery, Division of General Surgery and Organ Transplantation at the UCSC. Author ad co-author of several scientific works, mainly on the pathophysiology of surgical sepsis and trauma. Active part in several National and European multicentre clinical trials on conventional and non-conventional therapies in clinical sepsis.

Giovanni RestucciaGiovanni Restuccia, (MSc) is a Medical Biotechnologist with a solid background in genetics and molecular biology in pre-clinical and clinical research.

Further information

Istituto Malattie Infettive
Università Cattolica Sacro
L.go F.Vito 1
00168 Roma
Italy

www.policlinicogemelli.it
www.rm.unicatt.it



Top ^